drugset / Trial / NCT00359567

Comparative Study of Palonosetron With Granisetron as a Control in Patients Receiving Highly Emetogenic Chemotherapy

NCT00359567

Phase 3 Completed 1140 enrolled Taiho Pharmaceutical Co., Ltd.
RandomizedParallel-groupDouble-blindTreatment

Summary

To compare palonosetron with granisetron hydrochloride as a control in the efficacy of intravenous single dose in preventing acute and delayed gastro-intestinal disorders, such as nausea and vomiting induced by highly emetogenic chemotherapy.

Timeline

Start
2006-07
Primary completion
2007-05
Completion
2007-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Granisetron Other / unclassified 40 ug/kg Intravenous
Subject Palonosetron Other / unclassified 0.75 mg Intravenous